Report by Patrick Benning
Gene therapies, cancer treatment, personalized medicine: more than 100 partners from the research, medical and business sectors have joined forces a research cluster centered in the central German city of Heidelberg.The BioRN Cluster hopes to speed up the transformation of biomedical research into marketable products. Over the next five years the plan is to bring out 70 new medications that may offer new hope to patients.
